Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...

Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...